Hypoallergenic Infant Nutrition Boosts Growth of Amino Acid-Based Formula Market at 7.5% CAGR Through 2035

June 27, 2025 08:34 PM AEST | By EIN Presswire
 Hypoallergenic Infant Nutrition Boosts Growth of Amino Acid-Based Formula Market at 7.5% CAGR Through 2035
Image source: EIN Presswire

Amino acid-based formula market set for steady growth driven by rising food allergies, clinical adoption, and demand for specialized infant nutrition. ROCKVILLE, MD , MD, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- The global amino acid-based formula market is poised for significant growth, with market valuation expected to rise from USD 948.6 million in 2025 to approximately USD 1.955 billion by 2035. This growth reflects a strong compound annual growth rate (CAGR) of 7.5% over the forecast period from 2025 to 2035.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7073

Key Takeaways from Market Study:

The amino acid formula market is projected to reach US$ 1.955 billion by 2035.
The market is expected to grow at a CAGR of 7.5% from 2025 to 2035.
Growing-up milk (2–3 years) segment holds around 45% market share.
The 4–7 month age group segment is expected to expand at a CAGR of 7.8%.
First-age formula (0–3 months) accounts for over 20% of market value.
North America and Europe are the leading regional markets.
Asia-Pacific shows the fastest growth in market demand.
Powdered formula segment dominates due to longer shelf life.
Liquid ready-to-feed segment is expanding due to convenience-driven demand.
Market driven by increased cases of metabolic disorders and food allergies.

Leading Players Driving Innovation in the Amino Acid-Based Formula Market:

Key players in the amino acid-based formula industry include Nestlé, Abbott, Mead Johnson, Nutricia, Ausnutria, Kendamil, HiPP, Meiji, FrieslandCampina, and Bubs Australia.

Market Outlook and Key Drivers:

Amino acid-based formulas are elemental, hypoallergenic nutrition solutions used to manage complex conditions such as severe food allergies, metabolic disorders, eosinophilic esophagitis, and gastrointestinal syndromes. The market is gaining momentum due to increased clinical adoption, growing awareness among parents, and expanding application in therapeutic diets.

Pediatricians and dietitians are increasingly prescribing these formulas as primary solutions for infants and toddlers who cannot tolerate intact or hydrolyzed protein formulas. Furthermore, the rise of digital health technologies has enabled early diagnosis of gastrointestinal sensitivities, accelerating the demand for highly specialized nutritional products. Governments and healthcare providers in emerging markets are also supporting accessibility through public health programs and insurance coverage.

In addition, there is growing consumer demand for clean-label, non-GMO, and allergen-free formulations that offer optimized nutrient delivery, contributing to innovation and product diversification across the market.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=5174

Amino Acid-Based Formula Market News:

In April 2025, Abbott launched EleCare Jr with DHA & Lutein, an amino acid-based medical food for children with serious food allergies and GI disorders. It helps promote growth in children one year and older by delivering necessary nutrients and aiding protein malabsorption, malnutrition, and other food sensitivities.

More Valuable Insights on Offer:

Fact.MR, in its new offering, presents an unbiased analysis of the global Amino Acid-Based Formula Market presenting historical data for 2020 to 2024 and forecast statistics for 2025 to 2035.

The amino acid-based formula market is segmented by product type into follow-on milk, specialty infant milk, growing-up milk, and others. By type, it includes lactose and lactose-free variants. Based on point of sale, it is divided into prescription-based and OTC. By age group, segments include 0–3 months, 4–7 months, 8–12 months, and 12 months & above. Sales channels are offline (supermarkets, specialty outlets, pharmacies, others) and online (direct and third-party e-commerce). Regionally, it covers North America, Latin America, Western and Eastern Europe, East Asia, South Asia & Pacific, and the Middle East & Africa.

Check out More Related Studies Published by Fact.MR Research:

With the increasing demand for amino acid chelates in nutritional products, there is also a rise in traction of chelated minerals in dietary supplements for human nutrition attributable to increased health awareness. Most manufacturers advocate amino acid chelates as being safer for the body to use than non-chelated minerals.

The elemental formula market is expected to expand from a presumed USD 8.13 billion in 2025 to USD 16 billion in 2035 at a CAGR of 7%. This is owing to the factors like expanding incidences of food allergies, gastrointestinal diseases, and metabolic diseases that create the need for personalized nutrition.

About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.

Contact Us:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : [email protected]
Follow Us: LinkedIn | Twitter | Blog

S. N. Jha
Fact.MR
+1 628-251-1583
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.